2588
G. Kaur et al. / Tetrahedron 62 (2006) 2583–2589
134.42, 161.58, 170.77 ppm. HRMS (ESIC): calcd for
C62H56N6O4: 949.4442; found: 949.4479.
solvent was removed in vacuo. The resulted residue was
re-precipitated from DCM–hexane to give 6a in 12%. H
1
NMR (300 MHz, CDCl3) d: 2.44 (3H, s), 4.23 (2H, s), 5.03
(2H, s), 7.55 (4H, m), 7.67 (1H, d, JZ7.8 Hz), 7.89 (1H, d,
JZ7.5 Hz), 8.10–8.19 (4H, dd, JZ8.4 Hz), 8.59 (1H,
s) ppm. 13C NMR (100 MHz, CDCl3) d: 43.15, 51.55,
112.24, 119.33, 124.92, 125.88, 128.08, 128.34, 129.08,
129.32, 130.09, 131.00, 131.39, 131.72, 133.79,
144.71 ppm. HRMS (ESIC): calcd for C24H21BN2O2:
381.1774; found: 381.1774.
4.2.4. Compound (4b). The procedure was same as the
preparation of 4a from 2. Yield (20%). 1H NMR (400 MHz,
CD3OD/CDCl3) d: 2.37 (6H, s), 2.63 (6H, s), 3.80 (4H, s),
4.21 (10H, s), 5.73 (4H, s), 7.23 (4H, s), 7.56 (6H, t, JZ
8.0 Hz), 7.86 (2H, d, JZ8.0 Hz), 8.07 (2H, s), 8.12 (2H, d,
JZ8 Hz), 8.30 (4H, d, JZ8.4 Hz), 8.43 (4H, d, JZ
8.4 Hz) ppm. HRMS (ESIC): calcd for C60H58B2N6O10:
1045.4479; found: 1045.4523. We were unable to remove
cleaved neopentyl glycol, in order to confirm the structure;
the boronic acid was oxidized in the presence of acetic acid–
water (1/1) and H2O2 to obtain pure NMR. 1H NMR
(400 MHz, CDCl3) d: 2.44 (6H, s), 2.64 (6H, s), 3.80 (4H, s),
3.88 (4H, s), 4.73 (4H, s), 5.72 (4H, s), 6.64 (2H, d, JZ
6 Hz), 7.26 (3H, s), 7.52 (4H, t, JZ8 Hz), 7.62 (4H, t, JZ
6.8 Hz), 7.87 (2H, s), 7.95–7.93 (4H, dd, JZ2.4, 2.4 Hz),
8.41 (4H, t, JZ10 Hz) ppm. 13C NMR (100 MHz, CDCl3)
d: 29.71, 33.48, 39.36, 41.66, 42.01, 53.50, 59.39, 116.17,
121.81, 124.36, 124.65, 125.22, 125.32, 126.36, 126.57,
127.44, 128.38, 130.04, 130.82, 131.10, 134.35, 140.05,
163.70, 170.74 ppm. HRMS (ESIC): calcd for
C60H56N6O8: 989.4238; found: 989.4252.
4.2.7.
2-[(Anthracen-9-ylmethyl-methyl-amino)-
methyl]-4-nitro-boronic acid (6b). The procedure was
same as the preparation of 6a. Yield (29%). 1H NMR
(400 MHz, CDCl3) d: 2.25 (3H, s), 4.54 (2H, s), 5.15 (2H, s),
7.58 (4H, m), 7.97 (1H, d, JZ8 Hz), 8.14 (2H, d, JZ8 Hz),
8.24–8.28 (4H, dd, JZ5.6, 6 Hz), 8.64 (1H, s) ppm. 13C
NMR (100 MHz, CDCl3/CD3OD) d: 42.29, 121.80, 124.24,
124.90, 126.08, 126.77, 128.57, 129.17, 131.38, 131.95,
135.88, 141.96, 143.07, 148.50 ppm. HRMS (ESIC): calcd
for C23H21BN2O4: 401.1672; found: 401.1670.
4.2.8.
2-[(Anthracen-9-ylmethyl-methyl-amino)-
methyl]-4-fluoro-boronic acid (6c). The procedure was
same as the preparation of 6a. Yield (53%). 1H NMR
(300 MHz, CD3OD) d: 2.24 (3H, s), 3.98 (2H, s), 4.57 (2H,
s), 7.06 (2H, m), 7.42–7.44 (4H, dd, JZ2.7, 3.3 Hz), 7.79
(1H, s), 7.94–8.00 (4H, dd, JZ3, 13.2 Hz), 8.39 (1H,
s) ppm. 13C NMR (100 MHz, CDCl3/CD3OD) d: 38.39,
61.24, 112.81 (s (dC–F), JZ18 Hz), 115.52 (s (dC–F), JZ
19 Hz), 122.32, 123.64, 125.38, 127.84, 128.28, 130.01,
130.16, 134.69, 141.96, 162.69 (s (dC–F), JZ243 Hz) ppm.
HRMS (ESIC): calcd for C23H21BFNO2: 374.1727; found:
374.1717.
4.2.5. Compound (4c). The procedure was same as the
preparation of 4a from 2, but the hydrolysis was done in
solution of acetone–water (1/4) in total volume of 150 ml
and 1 N HCl (10 ml). The reaction was stirred vigorously
for 1 h at rt. The organic phase was washed with water (2!
10 ml), and dried over MgSO4 and solvent was removed in
vacuo. The resulted residue was re-precipitated from DCM–
1
ether to give 4c in 20%. H NMR (400 MHz, CD3OD/
CDCl3) d: 2.21 (6H, s), 2.42 (6H, s), 3.72 (4H, s), 4.11 (4H,
s), 4.60 (4H, s), 5.68 (4H, s), 7.09 (4H, q, JZ8.4, 9.6 Hz),
7.24 (4H, s), 7.48 (8H, s), 7.68 (2H, s), 8.27 (4H, s), 8.42
(4H, d, JZ6.4 Hz) ppm. HRMS (ESIC): calcd for
C60H58B2F2N4O6–H2O: 973.4483; found: 973.4464. We
were unable to remove cleaved neopentyl glycol, in order to
confirm the structure; the boronic acid was oxidized in the
presence of acetic acid–water (1/1) and H2O2 to obtain pure
Acknowledgements
Financial support from the National Institutes of Health
(CA88343, CA113917, and NO1-CO-27184), the Georgia
Cancer Coalition through a Distinguished Cancer Scientist
Award, and the Georgia Research Alliance through an
Eminent Scholar endowment and a Challenge grant is
gratefully acknowledged. We also acknowledge the support
of the Molecular Basis of Disease program at Georgia State
University for a fellowship in support of G.K.
1
NMR. H NMR (400 MHz, CDCl3) d: 2.34 (6H, s), 2.61
(6H, s), 3.79 (8H, s), 4.67 (4H, s), 5.29 (4H, s), 6.62 (2H, q,
JZ4.4, 4.8 Hz), 6.71 (2H, dd, JZ2.8 Hz), 6.77 (2H, d, JZ
2.8 Hz), 7.23 (4H, s), 7.52 (4H, t, JZ8.4 Hz), 7.60 (4H, t,
JZ8.4 Hz), 8.40–8.42 (8H, dd, JZ2.4, 2.8 Hz) ppm. 13C
NMR (100 MHz, CDCl3) d: 29.71, 39.31, 41.66, 41.75,
53.59, 59.97, 114.78 (s (dC–F), JZ14 Hz), 115.01 (s (dC–F),
JZ14 Hz), 116.49 (s (dC–F), JZ8 Hz), 122.69, 122.75,
124.63, 125.19, 126.29, 127.42, 129.14, 129.58, 130.08,
130.85, 131.07, 134.38, 153.11, 157.15 (s (dC–F), JZ
220 Hz), 170.72 ppm. HRMS (ESIC) calcd for
C60H56F2N4O4: 935.4348; found: 935.4351.
References and notes
1. Fukuda, M. Cell Surface Carbohydrates and Cell Develop-
ment; CRC: Boca Raton, 1992.
4.2.6.
2-[(Anthracen-9-ylmethyl-methyl-amino)-
2. Fukuda, M.; Hindsgaul, O. Molecular Glycobiology; Oxford
University Press: New York, 1994; pp 1–52.
methyl]-4-cyano-boronic acid (6a). Anthracen-9-
ylmethyl-methyl-amine (120 mg, 0.54 mmol), 3a (183 mg,
0.60 mmol), potassium carbonate (299 mg, 2.17 mmol) and
KI (7.2 mg) was dissolved in dried acetonitrile and mixed
for 12 h at rt. Solvent was removed and resulted yellow
precipitate was dissolved in (10 ml) DCM and 5 ml 10%
NaHCO3 and stirred for 1 h at rt. The organic phase was
washed with water (2!10 ml), and dried over MgSO4 and
3. Gabius, H.-J.; Gabius, S. Lectins and Glycobiology; Springer:
New York, 1993.
4. Garegg, P. J.; Lindberg, A. A. Carbohydrate Antigens;
American Chemical Society: Washington, DC, 1993.
5. Hakomori, S. Glycoconj. J. 2000, 17, 627–647.
6. Pickup, J. C.; Williams, G. Textbook of Diabetes; Blackwell
Science: Malden, MA, USA, 1997.